Q3 EPS Estimates for Journey Medical Raised by Roth Capital
Journey Medical Co. (NASDAQ:DERM – Free Report) – Roth Capital raised their Q3 2025 earnings per share (EPS) estimates for shares of Journey Medical in a research note issued on Thursday, March 27th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings of $0.10 per share for the quarter, up from […]
Journey Medical Co. (NASDAQ:DERM – Free Report) – Roth Capital raised their Q3 2025 earnings per share (EPS) estimates for shares of Journey Medical in a research note issued on Thursday, March 27th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings of $0.10 per share for the quarter, up from […]
